Literature DB >> 14693350

Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels.

Juan Bustillo1, Christina Wolff, Adan Myers-y-Gutierrez, Todd S Dettmer, Tom B Cooper, Andrea Allan, John Lauriello, C Fernando Valenzuela.   

Abstract

BACKGROUND: Proton magnetic resonance spectroscopy (1H-MRS) studies of schizophrenia suggest an effect of the disease or of antipsychotic medications on brain N-acetyl aspartate (NAA), a marker of neuronal viability. We studied in the rat the effect of antipsychotic drugs on NAA in several brain regions where NAA reductions have been reported in chronically medicated patients with schizophrenia.
METHODS: Three groups of nine rats each were treated with haloperidol (6 mg/kg/day), clozapine (70 mg/kg/day) and vehicle for 6 weeks and were sacrificed. Concentrations of NAA were determined by high-performance liquid chromatography (HPLC) from the following brain regions: cortex, striatum, thalamus, hippocampus and cerebellum.
RESULTS: Mixed-factorial ANOVA of NAA concentrations revealed no significant effect of drug group [F(2, 24) = 0.034; p = 0.966] or a group by brain region interaction [F(8, 44) = 0.841; p = 0.572]. There was a significant main effect of region [F(4, 21) = 6.104; p = 0.002] with higher NAA in the cortex.
CONCLUSIONS: These results are consistent with the only other study of the effect of typical and atypical antipsychotic drugs on NAA in the rat brain. The well-documented lower NAA in chronically treated schizophrenia patients is probably not a simple effect of antipsychotic medications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693350     DOI: 10.1016/s0920-9964(02)00528-5

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  6 in total

Review 1.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

2.  Long term antipsychotic treatment does not alter metabolite concentrations in rat striatum: an in vivo magnetic resonance spectroscopy study.

Authors:  Diana M Lindquist; R Scott Dunn; Kim M Cecil
Journal:  Schizophr Res       Date:  2011-03-22       Impact factor: 4.939

3.  Quantitative proton MR spectroscopy findings in the corpus callosum of patients with schizophrenia suggest callosal disconnection.

Authors:  K Aydin; A Ucok; S Cakir
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-26       Impact factor: 3.825

4.  1H-MRS at 4 tesla in minimally treated early schizophrenia.

Authors:  J R Bustillo; L M Rowland; P Mullins; R Jung; H Chen; C Qualls; R Hammond; W M Brooks; J Lauriello
Journal:  Mol Psychiatry       Date:  2009-11-17       Impact factor: 15.992

Review 5.  Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update.

Authors:  Juan R Bustillo
Journal:  Dialogues Clin Neurosci       Date:  2013-09       Impact factor: 5.986

6.  The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study.

Authors:  Vladimir Grošić; Petra Folnegović Grošić; Petra Kalember; Maja Bajs Janović; Marko Radoš; Mate Mihanović; Neven Henigsberg
Journal:  Neuropsychiatr Dis Treat       Date:  2014-07-07       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.